Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.48 USD | +0.03% | +0.03% | +37.51% |
Mar. 22 | Gilead Sciences Completes $4.3 Billion Cymabay Acquisition | MT |
Mar. 22 | CymaBay Therapeutics, Inc.(NasdaqGS:CBAY) dropped from NASDAQ Composite Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+37.51% | 3.73B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock CymaBay Therapeutics, Inc. - Nasdaq
- News CymaBay Therapeutics, Inc.
- CymaBay Therapeutics Launches Offering of Shares, Pre-Funded Warrants